Description: Daehan New Pharm Co., Ltd. manufactures and sells pharmaceuticals and animal health products in South Korea and internationally. The company offers pharmaceutical products, including cardiovascular, endocrine, neuropsychiatric, gastrointestinal, respiratory, musculoskeletal, osteoporosis, anti-cancer, urogenital, antifungal, antiviral hormone, dermatologic, central nervous, hormone, and antiobesity drugs, as well as antipyretic, analgesic, anti-inflammatory, and anti-infective drugs. It also provides antibiotics, antineoplastic, anticonvulsives, vitamins and others, amino acids, anesthetics, and inorganic products. In addition, the company offers animal health and nutrition products for poultry, cattle, sheep, swine, and fish; health supplements; and medical devices, as well as develops serum-free media for clinical application and fibroblast-based cell therapy. Daehan New Pharm Co., Ltd. was incorporated in 1984 and is headquartered in Hwaseong-si, South Korea.
Home Page: www.dhnp.co.kr
66 Jeyakgongdan 1-gil
Hwaseong-si,
18622
South Korea
Phone:
82 3 1353 6141
Officers
| Name | Title |
|---|---|
| Mr. Geon-U Bae | Chief Exec. Officer and Exec. Director |
| Young-Jun Song | VP and Exec. Director |
Exchange: KQ
Country: KR : Korea (Republic of)
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.741 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |